| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/29/2004 | WO2004035605A2 Glycoprotein synthesis |
| 04/29/2004 | WO2004035535A2 Erythrocyte differentiation factor, gene encoding same, and methods of use thereof |
| 04/29/2004 | WO2004035092A2 Use of an agent modulating cofilin expresion or activity for the treatment of inflammatory diseases |
| 04/29/2004 | WO2004035088A1 Therapeutics/diagnostics for brain tumor |
| 04/29/2004 | WO2004035087A1 Method for decreasing depression by inhibiting the activity of n-type calcium channel |
| 04/29/2004 | WO2004035086A2 Method for treatment of demyelinating central nervous system disease using gm-csf |
| 04/29/2004 | WO2004035085A1 Gene vaccine |
| 04/29/2004 | WO2004035082A2 Proteins involved in the regulation of energy homeostasis |
| 04/29/2004 | WO2004035008A2 Treatment of infections and other disorders |
| 04/29/2004 | WO2004035007A2 Transmucosal administration of aggregated antigens |
| 04/29/2004 | WO2004035006A2 Methods and compositions for immunization against hiv |
| 04/29/2004 | WO2004034977A2 Orally administered peptides synergize statin activity |
| 04/29/2004 | WO2004034971A2 Methods for treating and preventing sepsis using modified c1 inhibitor or fragments thereof |
| 04/29/2004 | WO2004034966A2 Substances for preventing and treating autoimmune diseases |
| 04/29/2004 | WO2004034956A2 8-plasmid method with mutated ha gene for producing an influenza vaccine |
| 04/29/2004 | WO2004034780A2 Method of producing recombinant proteins in the mammary gland of non-transgenic mammals |
| 04/29/2004 | WO2004020640A3 Zinc-regulated prokaryotic expression cassettes |
| 04/29/2004 | WO2004020606A9 Method of resisting osteoclast formation |
| 04/29/2004 | WO2004020464A3 Peptides able to switch between two structural states and their use |
| 04/29/2004 | WO2004016654A8 Il-8 like protein |
| 04/29/2004 | WO2004016151A3 Pthrp-derived modulators of smooth muscle proliferation |
| 04/29/2004 | WO2004014943A3 Biphalin derivates and their analgesic applications |
| 04/29/2004 | WO2004014311A3 Nogo receptor antagonists |
| 04/29/2004 | WO2004012675A3 Lipid binding molecules and methods of use |
| 04/29/2004 | WO2004009810A3 Transgenic animal models of hrv with humani icam-1 sequences |
| 04/29/2004 | WO2004007532A3 Beta-sheet forming peptides and material made thereof |
| 04/29/2004 | WO2004005346A3 Human nuclear hormone receptor |
| 04/29/2004 | WO2003104392A9 Improved reagents and methods for producing parvoviruses |
| 04/29/2004 | WO2003104282A8 Glycoprotein vi - fc fusion protein for treating vascular disorders |
| 04/29/2004 | WO2003097801A3 Cancer-linked gene as target for chemotherapy |
| 04/29/2004 | WO2003097684A8 Card-4 molecules and uses thereof |
| 04/29/2004 | WO2003096869A3 Recombinant bet. v. 1. allergen mutants, methods and process thereof |
| 04/29/2004 | WO2003095487A3 Immunogenic cd1 complexes |
| 04/29/2004 | WO2003089622A3 Novel genes, compositions, and methods for modulating the unfolded protein response |
| 04/29/2004 | WO2003080796A9 Ordered biological nanostructures formed from chaperonin polypeptides |
| 04/29/2004 | WO2003072712A3 A novel protein for inhibiting tumor progression and increasing nerve regeneration |
| 04/29/2004 | WO2003066828A3 Zinc finger libraries |
| 04/29/2004 | WO2003065973A3 Multivalent streptococcal vaccine compositions and methods for use |
| 04/29/2004 | WO2003060127A3 Genes and proteins involved in the biosynthesis of lipopeptides |
| 04/29/2004 | WO2003057134A3 Specific binding agents of human angiopoietin-2 |
| 04/29/2004 | WO2003054170A8 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells |
| 04/29/2004 | WO2003051305A3 Innate immune system-directed vaccines |
| 04/29/2004 | WO2003048187A3 Peptides and use thereof in therapeutic agents against hiv infection |
| 04/29/2004 | WO2003042399A9 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 04/29/2004 | WO2003032913A9 Methods and compositions for targeting proteins across the blood brain barrier |
| 04/29/2004 | WO2003031623A8 Cocoa flavour precursor peptides |
| 04/29/2004 | WO2003025171A9 Modulation of retinoic acid receptor gene expression and therapeutic uses thereof |
| 04/29/2004 | WO2003025156A9 Methods and apparatuses for purification |
| 04/29/2004 | WO2003012053A3 Identification of receptor and heparin binding sites in fgf4 by structure-based mutagenesis |
| 04/29/2004 | WO2003010196A3 Variants and exons of the glyt1 transporter |
| 04/29/2004 | WO2003009812A3 Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| 04/29/2004 | WO2003004683A3 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 04/29/2004 | WO2003004517A3 Peyers's patch and/or m-celle targeting ligands |
| 04/29/2004 | WO2002097082A8 Engineered biosynthesis of novel polyenes |
| 04/29/2004 | WO2002095395A8 Benzophenone-linked crf and crf-like peptides for covalent labeling of corticotropin-releasing factor (crf) binding protein |
| 04/29/2004 | WO2002095021A3 A repressor-mediated regulation system for control of gene expression in plants |
| 04/29/2004 | WO2002088380A9 Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof |
| 04/29/2004 | WO2002072630A3 Nucleic acid-associated proteins |
| 04/29/2004 | WO2002072612A3 Peptidic modulators of the androgen receptor |
| 04/29/2004 | WO2002070669A3 Secreted proteins |
| 04/29/2004 | WO2002066056A8 Synthetic vaccines comprising polyhydroxypolymer carriers |
| 04/29/2004 | WO2002038796A9 Methods for determining protease cleavage site motifs |
| 04/29/2004 | WO2002033067A8 Regulation of promoter activity using a polypeptide isolated from lactococcus lactis |
| 04/29/2004 | WO2002032941A8 The function of a haptoglobin-haemoglobin receptor and the uses thereof |
| 04/29/2004 | WO2001079274A8 Tuberculosis antigens and methods of use thereof |
| 04/29/2004 | WO1999028440A9 Nucleic acid encoding mammalian ubr1 |
| 04/29/2004 | WO1991013987A3 Cdna coding for the gene n of the viral haemorrhagic septicaemia virus and utilizations thereof |
| 04/29/2004 | WO1991000348A3 Modified vp1/p2a regions of the rhinoviral system |
| 04/29/2004 | US20040083505 Translocation codon; genetic engineered plants; gene expression of protein; blocking virus infections |
| 04/29/2004 | US20040083504 Sequence regulating the anther-specific expression of a gene and its use in the production of androsterile plants and hybrid seeds |
| 04/29/2004 | US20040083501 Gene for disease resistance plant; transformation of plant using polynucleotide |
| 04/29/2004 | US20040083497 Genetic engineering; induct immunology response using antibodies |
| 04/29/2004 | US20040082773 Modified PAR receptors, their preparation and their uses for selecting compounds which modulate PAR activity |
| 04/29/2004 | US20040082772 Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof |
| 04/29/2004 | US20040082771 Anti-apoptopic gene SCC-S2 and diagnostic and therapeutic uses thereof |
| 04/29/2004 | US20040082765 Immobilization; sustained release |
| 04/29/2004 | US20040082763 Diagnosis, therapy of Alzheimer's disease; synthetic antibody |
| 04/29/2004 | US20040082761 Cell adhesion proteins |
| 04/29/2004 | US20040082758 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 04/29/2004 | US20040082717 Keratin-silicone copolymers and interpenetrating networks (IPN's), methods of production and methods of use thereof |
| 04/29/2004 | US20040082532 Antifungal therapeutic targets |
| 04/29/2004 | US20040082531 Containing a transcription regulatory sequence derived from Human Cytomegalovirus major immediate early gene that includes exon 1, but not intron A; use of such vectors in vaccine and pharmaceutical compositions and gene therapy |
| 04/29/2004 | US20040082530 Nucleic acid immunization |
| 04/29/2004 | US20040082529 Treating or preventing cancer by administering to subject a vector comprising a heterologous polynucleotide operably linked to one or more regulatory sequences derived from an H19, IGF-1 or IGF-2 P4 transcriptional regulatory sequence |
| 04/29/2004 | US20040082516 For in vitro/vivo drugs; neuropathy |
| 04/29/2004 | US20040082515 Regulation of biological events using novel compounds |
| 04/29/2004 | US20040082513 Enzyme-mediated modification of fibrin for tissue engineering |
| 04/29/2004 | US20040082512 Drugs for treatment of inflammation/blood brain barrier degradation |
| 04/29/2004 | US20040082509 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/29/2004 | US20040082508 For diagnosis/treatment/prevention of cell proliferative/ autoimmune/inflammatory/cardiovascular/neurological diseases |
| 04/29/2004 | US20040082506 For treating hypophosphatemic rickets/osteomalacia/ osteoporosis/renal osteodystrophy/dialysis-associated bone diseases |
| 04/29/2004 | US20040082503 Comprises substituted human insulin B chain; drugs |
| 04/29/2004 | US20040082501 Compounds and method for the prevention and treatment of diabetic retinopathy |
| 04/29/2004 | US20040082039 Immunoglobulin fusion proteins |
| 04/29/2004 | US20040082038 Controlling cell proliferation, cell differentiation; genetic engineering |
| 04/29/2004 | US20040082037 Antiproliferative agents of vascular smooth muscles |
| 04/29/2004 | US20040082036 Modulation of hedgehog-mediated signaling pathway |
| 04/29/2004 | US20040082035 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/29/2004 | US20040082034 Stable hairpin structure; promoter joining to nucleotide sequence |
| 04/29/2004 | US20040082033 Genetic engineering; neutralizing antibodies; vaccines |